Therapeutic potential and pharmaceutical development of multitargeted polyphenolic compound ethyl gallate

Abstract

Ethyl gallate, a derivative of gallic acid, having significant characteristics including anti-inflammatory, antioxidant & antiviral, positioning it as potential candidate for therapeutic applications across several different illnesses, such as inflammatory condition, cancer, and viral illnesses like influenza, herpes simplex. Preclinical studies have shown that it has the capacity to modulate inflammation and oxidative stress, both of them plays significant roles in a variety of pathological diseases. The versatility of ethyl gallate in addressing a lot of disease pathways demonstrates its promise in integrated therapeutic methods. However, despite promising in vitro and animal model results, its clinical use remains unknown. The lack of human clinical studies leaves a significant vacuum in our findings, particularly of its safety, efficacy, and comprehensive pharmacological mechanisms. Future study is required to close this gap and establish the therapeutic value of ethyl gallate.